 |
 |
|
 |
 |
Product |
Ventana Biotech Inc’s main focus is the development of an appetite suppressing chewing gum or if higher dosages are needed in the form of an injection. The idea behind the product trying to emulate the body's natural signals for feeling full using a drug based on a natural gut hormone produced after every meal.
It is likely to be developed as an injectable drug first but our main focus is to take the product to the stage of eventually be taken orally and incorporated into a gum.
Ventana is not looking at a toxic drug, which has all sorts of side effects. Ventana is looking at the body's own way of switching off appetite after a meal.
In the western world, more than a 20% of adults are obese and of the remaining population half of men and a third of women are classified as overweight and early indications shows that the drug is able to reduce appetite with between 15% to 25%.
Drugs to tackle obesity often have unpleasant side effects, Ventana’s aim is to create a drug that will be free of side effects because it already circulates in the body. The body produces the hormone after every meal to ensure eating does not run out of control. There is evidence that some people have more of the hormone than others, and becoming overweight reduces the levels produced. |
|
|
|
 |
 |
|
 |
|
|
 |
